A detailed history of Legal & General Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Legal & General Group PLC holds 20,044,530 shares of BMY stock, worth $1.13 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares
20,044,530
Previous 20,044,530 -0.0%
Holding current value
$1.13 Billion
Previous $1.04 Billion -0.0%
% of portfolio
0.22%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $7.16 Million - $9.34 Million
-180,510 Reduced 0.89%
20,044,530 $1.04 Billion
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $29.6 Million - $39 Million
735,613 Added 3.77%
20,225,040 $840 Million
Q1 2024

Jul 01, 2024

BUY
$47.98 - $54.4 $7.74 Million - $8.77 Million
161,280 Added 0.83%
19,489,427 $1.06 Billion
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $23.2 Million - $26.3 Million
-482,862 Reduced 2.44%
19,328,147 $1.05 Billion
Q4 2023

Feb 15, 2024

BUY
$48.48 - $57.85 $136 Million - $163 Million
2,814,746 Added 16.56%
19,811,009 $1.02 Billion
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $25.4 Million - $28.4 Million
-438,424 Reduced 2.51%
16,996,263 $986 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $54.6 Million - $60.6 Million
856,985 Added 5.17%
17,434,687 $1.11 Billion
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $4.57 Million - $5.18 Million
69,552 Added 0.42%
16,577,702 $1.15 Billion
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $450,461 - $533,410
6,578 Added 0.04%
16,508,150 $1.19 Billion
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $71,706 - $42.4 Million
-551,586 Reduced 3.23%
16,501,572 $1.17 Billion
Q2 2022

Aug 22, 2022

BUY
$72.62 - $79.98 $49 Million - $54 Million
674,921 Added 4.12%
17,053,158 $1.31 Billion
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $73.1 Million - $87.6 Million
1,188,644 Added 7.83%
16,378,237 $1.2 Billion
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $33.9 Million - $39.5 Million
-632,124 Reduced 4.0%
15,189,593 $947 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $43.9 Million - $51.4 Million
741,489 Added 4.92%
15,821,717 $936 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $43.2 Million - $47 Million
697,349 Added 4.85%
15,080,228 $1.01 Billion
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $5.06 Million - $5.69 Million
-85,320 Reduced 0.59%
14,382,879 $908 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $9 Million - $10.2 Million
155,917 Added 1.09%
14,468,199 $897 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $25.7 Million - $28.5 Million
-447,296 Reduced 3.03%
14,312,282 $863 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $37.8 Million - $44.2 Million
-689,293 Reduced 4.46%
14,759,578 $868 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $10.9 Million - $15.8 Million
234,035 Added 1.54%
15,448,871 $862 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $224 Million - $293 Million
4,558,218 Added 42.77%
15,214,836 $977 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $2.84 Million - $3.37 Million
66,392 Added 0.63%
10,656,618 $540 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $18.6 Million - $20.5 Million
415,853 Added 4.09%
10,590,226 $480 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $72.5 Million - $86.4 Million
1,605,928 Added 18.74%
10,174,373 $485 Million
Q4 2018

Feb 15, 2019

BUY
$48.76 - $63.23 $23.2 Million - $30 Million
474,820 Added 5.87%
8,568,445 $445 Million
Q3 2018

Nov 20, 2018

BUY
$55.19 - $62.25 $6.71 Million - $7.57 Million
121,647 Added 1.53%
8,093,625 $502 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $3.36 Million - $4.19 Million
-66,471 Reduced 0.83%
7,971,978 $441 Million
Q1 2018

May 17, 2018

SELL
$59.92 - $68.98 $26.7 Million - $30.7 Million
-445,262 Reduced 5.25%
8,038,449 $508 Million
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $509 Million - $554 Million
8,483,711
8,483,711 $520 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.